发明授权
US5874275A Polypeptides having mutanase activity and nucleic acids encoding same
失效
具有转录酶活性的多肽和编码相同的核酸
- 专利标题： Polypeptides having mutanase activity and nucleic acids encoding same
- 专利标题（中）： 具有转录酶活性的多肽和编码相同的核酸
-
申请号： US956268申请日： 1997-10-22
-
公开(公告)号： US5874275A公开(公告)日： 1999-02-23
- 发明人: Randy M Berka , Stephan Christgau , Torben Halkier , Jeff Shuster , Claus Crone Fuglsang
- 申请人： Randy M Berka , Stephan Christgau , Torben Halkier , Jeff Shuster , Claus Crone Fuglsang
- 申请人地址： DKX Bagsvaerd CA Davis
- 专利权人： Novo Nordisk A/S,Novo Nordisk Biotech, Inc.
- 当前专利权人： Novo Nordisk A/S,Novo Nordisk Biotech, Inc.
- 当前专利权人地址： DKX Bagsvaerd CA Davis
- 主分类号： C12N15/09
- IPC分类号： C12N15/09 ; C07K19/00 ; C12N1/15 ; C12N1/19 ; C12N1/21 ; C12N9/24 ; C12N15/00 ; C12N15/55 ; C12R1/07 ; C12R1/46 ; C12R1/465 ; C12R1/645 ; C12R1/66 ; C12R1/72 ; C12R1/77 ; C12R1/785 ; C12R1/80 ; C12R1/84 ; C12R1/85 ; C07H21/04 ; C12N1/20
摘要：
The present invention relates to polypeptides having mutanase activity and isolated nucleic acid sequences encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid sequences as well as methods for producing the polypeptides. The present invention further relates to oral cavity compositions and methods for degrading mutan.
公开/授权文献
- US5222944A Safety syringe with retractable and lockable needle 公开/授权日：1993-06-29
信息查询
IPC分类:
